CoolPrevent
| Reference number | |
| Coordinator | BrainCool AB (publ) |
| Funding from Vinnova | SEK 500 000 |
| Project duration | December 2018 - December 2019 |
| Status | Completed |
Important results from the project
The purpose of the project has been to carry out a fesability study with the aim of working out a complete business plan to seek further financing for the project through venture capital or non-dilutive financing eg. through EU funding. The goal has been met and the project will enter the next phase when a study to prevent oral mucositis is completed. Study items 1. Define technical requirements via user studies, 2. Define the segments of the target population for market entry. ’3. Define the clinical plan 4. Define the pricing strategy 5. Consolidate all findings in a detailed business plan.
Expected long term effects
The result of the project is that the company´s project in prevention of oral mucositis will be launched in conjunction with results and publication will be presented during one of the major scientific cancer conferences in 2020. A business plan has been drawn up and supplementary funding will be applied for to complete development and clinical development in the second area of prevention of chemo-induced neuropathy.
Approach and implementation
The project has been carried out by conducting a fesability study as follows A user study to define the technical requirements for a hand and foot cooling product to counter neuropathy. Tests have been carried out with healthy volunteers and further development of concepts has been carried out in collaboration with Kapacitet A / S User studies have been conducted at Akademiska US in Uppsala. A market study and analysis of both applications Price analysis and sensitivity analysis as well as an evaluation of the conditions for obtaining insurance compensation (reimbursement)